Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.
2.

MAPK signaling pathways and HDAC3 activity are disrupted during differentiation of emerin-null myogenic progenitor cells.

Collins CM, Ellis JA, Holaska JM.

Dis Model Mech. 2017 Apr 1;10(4):385-397. doi: 10.1242/dmm.028787. Epub 2017 Feb 10.

3.

Diseases of the Nucleoskeleton.

Holaska JM.

Compr Physiol. 2016 Sep 15;6(4):1655-1674. doi: 10.1002/cphy.c150039. Review. Erratum in: Compr Physiol. 2017 Jun 18;7(3):1083.

4.

LMO7-null mice exhibit phenotypes consistent with emery-dreifuss muscular dystrophy.

Mull A, Kim G, Holaska JM.

Muscle Nerve. 2015 Feb;51(2):222-8. doi: 10.1002/mus.24286. Epub 2014 Nov 19.

PMID:
24825363
5.

Emerin in health and disease.

Koch AJ, Holaska JM.

Semin Cell Dev Biol. 2014 May;29:95-106. doi: 10.1016/j.semcdb.2013.12.008. Epub 2013 Dec 21. Review.

6.

Emerin and histone deacetylase 3 (HDAC3) cooperatively regulate expression and nuclear positions of MyoD, Myf5, and Pax7 genes during myogenesis.

Demmerle J, Koch AJ, Holaska JM.

Chromosome Res. 2013 Dec;21(8):765-79. doi: 10.1007/s10577-013-9381-9. Epub 2013 Sep 24.

7.

Loss of emerin alters myogenic signaling and miRNA expression in mouse myogenic progenitors.

Koch AJ, Holaska JM.

PLoS One. 2012;7(5):e37262. doi: 10.1371/journal.pone.0037262. Epub 2012 May 11.

8.

The nuclear envelope protein emerin binds directly to histone deacetylase 3 (HDAC3) and activates HDAC3 activity.

Demmerle J, Koch AJ, Holaska JM.

J Biol Chem. 2012 Jun 22;287(26):22080-8. doi: 10.1074/jbc.M111.325308. Epub 2012 May 8.

9.

Emerin inhibits Lmo7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes.

Dedeic Z, Cetera M, Cohen TV, Holaska JM.

J Cell Sci. 2011 May 15;124(Pt 10):1691-702. doi: 10.1242/jcs.080259. Epub 2011 Apr 26.

10.

Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice.

Puckelwartz MJ, Kessler E, Zhang Y, Hodzic D, Randles KN, Morris G, Earley JU, Hadhazy M, Holaska JM, Mewborn SK, Pytel P, McNally EM.

Hum Mol Genet. 2009 Feb 15;18(4):607-20. doi: 10.1093/hmg/ddn386. Epub 2008 Nov 13.

11.

Emerin and the nuclear lamina in muscle and cardiac disease.

Holaska JM.

Circ Res. 2008 Jul 3;103(1):16-23. doi: 10.1161/CIRCRESAHA.108.172197. Review.

PMID:
18596264
13.

Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes.

Holaska JM, Rais-Bahrami S, Wilson KL.

Hum Mol Genet. 2006 Dec 1;15(23):3459-72. Epub 2006 Oct 26.

PMID:
17067998
14.

Multiple roles for emerin: implications for Emery-Dreifuss muscular dystrophy.

Holaska JM, Wilson KL.

Anat Rec A Discov Mol Cell Evol Biol. 2006 Jul;288(7):676-80. Review.

15.

Nuclear membrane protein emerin: roles in gene regulation, actin dynamics and human disease.

Wilson KL, Holaska JM, Montes de Oca R, Tifft K, Zastrow M, Segura-Totten M, Mansharamani M, Bengtsson L.

Novartis Found Symp. 2005;264:51-58; discussion 58-62, 227-30. Review.

PMID:
15773747
16.
17.

Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy.

Haraguchi T, Holaska JM, Yamane M, Koujin T, Hashiguchi N, Mori C, Wilson KL, Hiraoka Y.

Eur J Biochem. 2004 Mar;271(5):1035-45.

PMID:
15009215
18.

Emerin interacts in vitro with the splicing-associated factor, YT521-B.

Wilkinson FL, Holaska JM, Zhang Z, Sharma A, Manilal S, Holt I, Stamm S, Wilson KL, Morris GE.

Eur J Biochem. 2003 Jun;270(11):2459-66.

19.

Transcriptional repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro.

Holaska JM, Lee KK, Kowalski AK, Wilson KL.

J Biol Chem. 2003 Feb 28;278(9):6969-75. Epub 2002 Dec 18.

20.

Ca2+-dependent nuclear export mediated by calreticulin.

Holaska JM, Black BE, Rastinejad F, Paschal BM.

Mol Cell Biol. 2002 Sep;22(17):6286-97.

Supplemental Content

Loading ...
Support Center